Senti Biosciences, Inc. SNTI 深 沪
交易中 03-27 10:02:09 美东时间
0.8379
-0.043
-4.94%
华盛通- 最 高1.016
- 今 开0.8614
- 成交量 8.43万股
- 最 低 0.82
- 昨 收 0.8814
- 总市值 3.71万
- 52周最高 5.10
- 市盈率 静 --
- 换手率 190.53%
- 52周最低 0.797
- 委 比 9.09%
- 总股本 4.42万
- 历史最高 16.94
- 量 比 25.77
- 振 幅 22.24%
- 历史最低 0.2111
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Senti Bio Granted U.S. FDA Orphan Drug Designation for Use of First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, SENTI-202 to Treat Acute Myeloid Leukemia
Senti Biosciences announced that the FDA granted Orphan Drug Designation to SENTI-202 for treating relapsed/refractory AML. The drug, an off-the-shelf Logic-Gated CAR NK cell therapy, is in Phase 1 clinical trials and targets CD33 and/or FLT3-expressing cancers while sparing healthy cells. Orphan Drug Designation provides incentives for developing treatments for rare diseases.
2025-06-18 11:00
Senti Biosciences Announces New Employment Inducement Grants
Senti Biosciences granted stock options to eight new employees, totaling 102,500 shares at $3.03 per share, under its 2022 Inducement Equity Plan. The company focuses on developing next-generation cell and gene therapies using its Gene Circuit platform to treat incurable diseases.
2025-06-09 20:30
Senti Bio to Participate in a Virtual Fireside Chat Hosted by Chardan Capital Markets, LLC
Senti Biosciences will host a virtual fireside chat with company executives and Chardan analyst Geulah Livshits, PhD, on June 9, 2025 at 3:00 PM ET. The discussion will focus on the company's next-generation cell and gene therapies using its proprietary Gene Circuit platform.
2025-06-06 13:05
Senti Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
Senti Biosciences' CEO Timothy Lu will present at the Webull Virtual Biotech Investment Webinar on May 29, 2025, discussing the company's innovative gene and cell therapies.
2025-05-22 20:05
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Tenon Medical (NASDAQ:TNON) shares increased by 28.2% to $5.16 during ...
2024-09-25 22:42
